NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #163Pancreatogenic Type 3c Diabetes - Underestimated, Underappreciated and Poorly Managed
Type 3c diabetes, also known as pancreatogenic diabetes, refers to diabetes resulting from pancreatic disease, including pancreatitis, cystic fibrosis and pancreatic cancer. It is difficult to diagnose, and for many, management is challenging due to erratic swings from hypoglycemia to hyperglycemia caused by metabolic abnormalities due to pancreatic tissue damage. This review aims to describe the disease along with its characteristics, diagnosis, complications, and management.
FRONTIERS IN ENDOSCOPY, SERIES #36Current Practice Patterns for Esophageal Stenting in Malignancy - A Web-Based Survey of Endoscopists Who Place Self Expanding Metal Stents
Dysphagia is the most common presenting symptom in patients with advanced esophageal cancer (EC). Difficulty managing oral secretions and eating solid food has a significant negative impact on their quality of life. In the current clinical environment, there is an understanding of the risks and benefits of self-expanding metal stents (SEMS) for malignant dysphagia, with most patients having excellent clinical outcomes and serious adverse events being relatively uncommon. To analyze trends in esophageal SEMS, we conducted a web-based survey to better understand the practice patterns of physicians who place SEMS and to poll their opinions about unmet needs in this clinical space.
DISPATCHES FROM THE GUILD CONFERENCE, SERIES #4Rheumatologic Complications of Inflammatory Bowel Diseases
Beyond gastrointestinal symptoms and complications, IBD is a systemic disease that is frequently accompanied by extraintestinal manifestations (EIM) involving virtually every organ in the body. Rheumatologic extraintestinal manifestations and complications are common, presenting as peripheral arthritis and/or axial arthritis which can add to the detrimental impact that IBD has on affected patients in terms of pain, quality of life and functional status. Here we discuss the importance of a high index of suspicion and early treatment, which may decrease healthcare burden.
A CASE REPORTAn Uncommon Cause of Dysphagia in a 35 Year Old Male
SAN DIEGO - Prometheus Laboratories Inc.—a Nestlé Health Science company—announced the launch of IBcause™, an all-in-one convenient test that evaluates a unique combination of 20 stool and serum measures all at 1 time. IBcause will assist healthcare providers in diagnosing many common causes of persistent diarrhea.
INTRODUCING PROMETHEUS® IBcause™ - CONVENIENT ALL-IN-ONE DIAGNOSTIC TESTFOR PERSISTENT DIARRHEA
20 YEAR OLD KIBOW BIOTECH FURTHER VALIDATES ENTERIC DIALYSIS® CONCEPT, WITH GREATER UNDERSTANDING OF MODULATING THE GUT MICROBIOME WITH PRO/PREBIOTICS TOWARDS MAINTAINING HEALTHY KIDNEY FUNCTION
NEWTOWN SQUARE, PA - One of the world's prominent meetings in nephrology, the ISN World Congress of Nephrology was held in Mexico City, Mexico from April 21st-25th (wcn2017.org/). Kibow has been participating at this bi-annual event since 2005 held successively in Singapore, Hong Kong, Milan, Rio De Janerio, Vancouver, Cape Town, and this year in Mexico City. Concurrently, Kibow Biotech is also attending the NKF Spring Clinical Meeting in Orlando, Florida (kidney.org/spring-clinical).
June 10-14, 2017 - American Society of Colon and Rectal Surgeons Annual Scientific Tripartite Meeting
July 22, 2017 - Mastering Clinical Challenges and Emerging Therapies in IBD
October 13-18, 2017 World Congress of Gastroenterology (WCOG) at ACG 2017